Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2013

View Archived Issues

Fumarate increased in ER-negative breast cancer in African American women

BB2 receptor expression elevated in low-grade PIN

Cancer Research Technology and AstraZeneca extend cancer metabolism alliance

RXi Pharmaceuticals and OPKO Health pool RNAi assets

OncoMed begins dosing in phase I trial of anti-Notch 1 antibody in solid tumors

Otsuka Pharmaceutical patents novel STEP inhibitors

Patrys reports additional data from phase I/IIa PAT-SM6 study

Acceleron begins new phase II trial to investigate ACE-536 in beta-thalassemia

Pernix Therapeutics completes acquisition

FDA advisory committee votes against salmon calcitonin use

Lpath and Provista Diagnostics collaborate to develop cancer diagnostics

CoCo Therapeutics founded to advance research findings in Alzheimer's disease

Qu Biologics commences phase I/II trial in Crohn's disease

Protalix gains approval to initiate study of oral treatment for Gaucher's disease in Israel

NeoStem to proceed with PreSERVE AMI phase II trial following second interim review

ITX-5061 proves safe, effective and virologically active following oral dosing

First in-human pharmacokinetic study for DA-0831

Korean researchers present clinical data for DP-R206 and ibandronate

HanAll BioPharma patents new AMPK inhibitors

Nippon Shinyaku patents novel MPGES-1 inhibitors

Researchers at Boehringer Ingelheim synthesize new sGC activators

Canadian team discloses new agents for cancer

Takeda seeks European approval of vedolizumab

Roche ends fibrosis alliance with Galapagos

Novel mutations in the ECM1 gene identified in siblings with lipoid proteinosis

APT imaging is able to differentiate high-grade brain tumors

Health Canada approves mirabegron

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...